DNA Testers On Notice As FDA Warns Wife Of Google's Brin

Law360, New York (November 25, 2013, 6:29 PM EST) -- The U.S. Food and Drug Administration on Monday delivered a high-profile jolt to the booming field of personalized medicine by ordering a halt to sales of genetic tests by the wife of Google Inc. co-founder Sergey Brin, putting manufacturers on notice that regulators are getting tough after years of leeway, experts say.

In a warning letter to 23andMe Inc., FDA demanded that the company “immediately discontinue” sales of a $99 DNA-screening kit, saying the unapproved product could result in dangerous false positives or negatives.

Headed by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.